From: Assessment of the societal cost of Taenia solium in Angónia district, Mozambique
Parameter | Mean (95% UIb) | Distributions | Reference |
---|---|---|---|
Mortality due to epilepsy per 1000 | 0.08 (0.076–0.084) | Uniform (7.6e-05, 8.4e-05) | [28] |
Prevalence of active epilepsy (%) | 1.3 (0.8–1.9) | Beta (22, 1701) | [15] |
Proportions | |||
Epilepsy associated to NCC (%) | 51 (43–59) | Uniform (0.427, 0.592) | [15] |
Epilepsy patients receiving treatment (%) | 15 (9.4–21) | Beta (22, 129) | [15] |
Headache among people with lifetime epilepsy (%) | 62 (54–70) | Beta (94, 57) | [23] |
Migraine among people with headache and epilepsy (%) | 39 (30–50) | Beta (37, 57) | [23] |
Tension-type headache among people with headache and epilepsy (%) | 61 (50–70) | Beta (57, 37) | [23] |
Disability weights | |||
Epilepsy | GBDc 2010 [31] | ||
Untreated | 0.426 (0.286–0.565) | Uniform (0.279, 0.572) | |
Treated, seizure free | 0.076 (0.048–0.105) | Uniform (0.047, 0.106) | |
Headache | GBDc 2013 [32] | ||
Migraine | 0.441 (0.301–0.581) | Uniform (0.294, 0.588) | |
Tension-type | 0.040 (0.023–0.056) | Uniform (0.022, 0.057) |